Article

Ablation of Deubiquitinase USP15 Ameliorates Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

2022-08-25

Abstract excerpt

<title>Abstract</title> <p>Non-alcoholic fatty liver disease <bold>(</bold>NAFLD) occurs due to the accumulation of fat in the liver, leading to fatal liver diseases such as non-alcoholic steatohepatitis (NASH) and cirrhosis. Elucidation of the molecular mechanisms underlying NAFLD is critical for its prevention and therapy. Here, we observed deubiquitinase USP15 expression was upregulated in mouse livers fed a h...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2f31f918-a28e-5922-84ee-ab2d3f6953ec
DOI: 10.21203/rs.3.rs-1826647/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Ablation of Deubiquitinase USP15 Ameliorates Non-Alcoholic Fatty Liver Disease and Non-Alcoholic SteatohepatitisDOI 10.21203/rs.3.rs-1826647/v1Read

The role of ubiquitination and deubiquitination in the pathogenesis of non-alcoholic fatty liver diseaseSemantic proximity Read

Systematic Analysis of UFMylation Family Genes in Tissues of Mice with Metabolic Dysfunction-Associated Steatotic Liver DiseaseSemantic proximity Read

USP15 Participates in Hepatitis C Virus Propagation through Regulation of Viral RNA Translation and Lipid Droplet FormationSemantic proximity Read

Fat Mass and Obesity–Associated Protein Promotes Liver Steatosis By Targeting PPARαSemantic proximity Read

Deubiquitinase USP1 enhances CCAAT/enhancer-binding protein beta (C/EBPβ) stability and accelerates adipogenesis and lipid accumulationSemantic proximity Read

Lysosomal-associated protein transmembrane 5 ameliorates non-alcoholic steatohepatitis through degradating CDC42Semantic proximity Read

MAPK15 PROTECTS AGAINST THE DEVELOPMENT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASESemantic proximity Read

USP11 promotes lipogenesis and tumorigenesis by regulating SREBF1 stability in hepatocellular carcinomaSemantic proximity Read

Loss of hepatic Flcn protects against fibrosis and inflammation by activating autophagy pathways.Semantic proximity Read

HSD17B13: A Potential Therapeutic Target for NAFLDSemantic proximity Read

Loss of hepatic Lgr4 and Lgr5 promotes nonalcoholic fatty liver diseaseSemantic proximity Read

The emerging role of E3 ubiquitin ligases and deubiquitinases in metabolic dysfunction-associated steatotic liver diseaseSemantic proximity Read